logo

For the Inventor, By the Inventor

Blacksburg, VA, United States of America

William Hugold Velander

This inventor holds 17 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Virginia Tech Intellectual Properties Inc., American Red Cross, American National Red Cross. Active years: 1994-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Hugold Velander. Retrieved from https://idiyas.com/inventor/william-hugold-velander

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 76.5


Average Co-Inventor Count = 3.3

ph-index = 8

Forward Citations = 187(Granted Patents)


Company Filing History:

goldMedal8 out of 823 
 
Virginia Tech Intellectual Properties Inc.
 patents
silverMedal3 out of 12 
 
American Red Cross
 patents
bronzeMedal2 out of 71 
 
American National Red Cross
 patents
4. 2 out of 142 
 
Center for Innovative Technology
 patents
5. 2 out of 3,693 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
6. 2 out of 1,326 
 
The University of North Carolina at Chapel Hill
 patents
7. 1 out of 22,379 
 
3M Innovative Properties Company
 patents
8. 1 out of 2 
 
Progenetics LLC
 patents
9. 1 out of 1 
 
Virginia Intellectual Property Division
 patent
10. 4 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1994-2011

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 7888321 - Production of high levels of transgenic factor IX without gene rescue, and its therapeutic uses (2011-02-15),
2. 7867974 - Induction of tolerance by oral administration of factor VIII and treatment of hemophilia (2011-01-11),
3. 7435869 - Transgenic nonhuman mammals producing fibrinogen in milk and methods of producing fibrin (2008-10-14),
4. 7419948 - Treatment of hemophilia with human Factor IX produced in mammary tissue of transgenic mammals (2008-09-02),
5. 7220718 - Oral treatment of hemophilia (2007-05-22),
6. 6984772 - Transgenic non-human mammals producing fibrinogen in their milk (2006-01-10),
7. 6518482 - Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor (2003-02-11),
8. 6344596 - Expression of active human factor IX in mammary tissue and of milk non human transgenic mammals (2002-02-05),
9. 6262336 - Expression of a heterologous protein C in mammary tissue of transgenic animals using a long whey acidic protein promoter (2001-07-17),
10. 6255554 - Transgenic non-human mammals expressing human coagulation factor VIII and von Willebrand factor (2001-07-03),
11. 6194552 - Immunosorbents with developed binding efficiency and method of manufacture (2001-02-27),
12. 5977345 - Inside-out crosslinked and commercial-scale hydrogels, and (1999-11-02),
13. 5907016 - Method of coupling ligands onto supports and products produced therefrom (1999-05-25),
14. 5880327 - Transgenic mammals expressing human coagulation factor VIII (1999-03-09),
15. 5589604 - Expression of human protein C in mammary tissue of transgenic mammals (1996-12-31),

Title: The Innovative Journey of William Hugold Velander

Introduction: William Hugold Velander is a renowned inventor based in Blacksburg, VA (US) known for his groundbreaking contributions to various fields.

Latest Patents: William Hugold Velander holds several patents in the areas of renewable energy technologies, medical devices, and sustainable materials.

Career Highlights: With a career spanning over two decades, Velander has worked on numerous projects that have revolutionized industries such as biotechnology, electronics, and environmental science.

Collaborations: Throughout his career, William Hugold Velander has collaborated with leading research institutions, universities, and companies to bring his innovative ideas to life.

Conclusion: William Hugold Velander's passion for innovation and dedication to creating a positive impact on society continue to inspire the next generation of inventors.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…